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Conclusion: The proposed iterative 4D CBCT reconstruction 
algorithm is more than an order of magnitude faster than 
other iterative algorithms described in the literature. It 
produces sharp, streak free images from standard 60s 
acquisitions used for 3D CBCT. For purposes such as patient 
setup and verification of tumour motion, the fast 
reconstruction algorithm presented enables online usage of 
4D CBCT as a part of the clinical treatment routine. 
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Purpose or Objective: Radiotherapy treatment planning for 
use with high-energy photon beams currently employs a 
binary approach when defining the PTV. Current approach 
using van Herk’s 3D margin recipe (VHMR) may require 
additional modifications if the PTV overlaps with OARs. Our 
novel approach aims to move away from the binary treatment 
of PTVs, where each voxel is categorised as either target or 
non-target, and generate PTVs with voxels that may be 
considered part PTV and part OAR, providing the optimiser 
with additional information to more easily tackle conflicting 
dose constraints. We investigate the impact of this novel 
approach when applied to prostate radiotherapy treatments, 
and compare treatment plans generated using our approach 
and VHMR.  
 
Material and Methods: Following the principles laid out in 
VHMR, only geometrical uncertainties are considered. We 
explore the use of 2D margins, motivated by the fact that 
small displacements in beam direction result in negligible 
change in dose delivered to the target. Only uncertainties 
perpendicular to the incident beam direction are considered, 
and therefore safety margins are generated for each beam 
direction. The degree of overlap of these beam specific 
margins is normalised and used to assign a weighting factor 
defined as the ratio of target-to-OAR content to a specific 
voxel. The objective function employed in the inverse 
planning process uses these local weighting factors for voxels 
of the CTV and OAR, should an overlap occur.  
Five prostate radiotherapy plans were generated using IMRT 
inverse planning. The prostate was given a prescription of 
78Gy in 2Gy fractions. Systematic uncertainties of 1.1mm, 
1.1mm and 1.5mm in the LR, SI and AP directions, 
respectively, and 2.2mm, 2.1mm, 3.2mm for the random 
uncertainties, were used. Plans were generated such that the 
static dose distribution conforms to requirements outlined in 
the PACE clinical trial.  
A verification tool was used to perform Monte Carlo 
simulations to model the cumulative dose of the ROI when it 
is displaced due to the presence of uncertainties; statistics 
from the tool are used for plan comparison.  
 
Results: We used a population of 50,000 for simulation. We 
observed a median of 96.7% and 100% of the population CTV 
receiving D98% > 95% Dpres for our approach and VHMR 
respectively. Both values are higher than the 90% population 
requirement as stated in the VHMR derivation, and this is a 
direct consequence of the imperfect conformality of the dose 
distribution. When looking at rectal doses, we observed an 
improvement of 20.2% to 89.2% of the population satisfying 
D2% < 70Gy using our method; table 1 shows the results of 




Conclusion: We observed a significant decrease of high rectal 
doses delivered whilst maintaining sufficient dose coverage 
of the CTV, though the amount of sparing depends largely on 
the patient’s anatomy and the objectives chosen for 
optimisation.  
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Purpose or Objective: This study examines the radiation-
induced changes in regional lung perfusion according to the 
dose level in the lungs in 58 NSCLC patients treated with 
chemo-radiotherapy (RT). The purpose of the study was to 
assess dose and time dependence of RT-induced changes in 
regional lung function measured with single photon emission 
computed tomography (SPECT) and establish a correlation 
with the development of radiation pneumonitis (RP). 
 
Material and Methods: NSCLC patients scheduled to receive 
RT of minimum 60 Gy were included prospectively in the 
study. Lung perfusion SPECT/CT was performed on a dual-
head SPECT/CT camera in the treatment position before and 
1, 3, 6 and 12 months after RT. Reconstructed SPECT/CT 
data were fused with the planning CT using MIM Software. 
Dose to the whole lung was segmented into regions of 0-5, 5-
20, 20-40, 40-60 and >60 Gy. Regional perfusion was 
calculated from SPECT for each dose bin. Changes (relative 
to baseline, %) in regional lung perfusion were correlated 
with regional dose. A total of 58 patients with baseline SPECT 
were treated with IMRT. Of these 51 had 1 month follow-up 
(FU) scans, 45 had 3 months scans, 34 had 6 months scans 
and 23 had 12 months scans. Toxicity was assessed 
prospectively and graded by CTC-AE version 4 for radiation 
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pneumonitis. Patients with minimum grade 2 were considered 
as RP. 
 
Results: Composite perfusion changes were associated with 
dose. Statistically significant dose-dependent reduction in 
regional perfusion was observed at 3, 6 and 12 months FU. 
Comparison of dose-response curves based on their slopes 
showed a dose-dependent reduction in perfusion at all time 
intervals (R2=0.8-0.9) except 1 month (R2=0.4). Relative 
perfusion loss per dose bin was 4% at 1 month, 14% at 3 
months, 13% at 6 months and 21% at 12 months FU (Figure 1).  
 
The dose-response relations varied between patients with or 
without RP. In patients who developed RP, perfusion 
reduction was larger in 20-40 Gy dose bin at 3 months FU 
(p=0.04), and in >60 Gy dose bin at 6 months (p=0.03), 
compared to those without the complication. Low dose 
regions, on the contrary, revealed larger perfusion increase 
at 12 months FU in the patients with RP (p=0.002). 
 
Conclusion: Progressive dose dependent perfusion loss was 
seen on SPECT up to 12 months following IMRT. Patients with 
radiation pneumonitis demonstrate a larger perfusion loss in 
the high dose regions, as well as relatively larger perfusion 
increase in regions receiving low dose, possibly due to 
function being shunted to these areas. 
 
OC-0382  
A novel concept to tumour targeting: inverse dose-painting 
or targeting the "Low uptake drug volume" 
A. Yaromina
1MAASTRO clinic, Radiation Oncology, Maastricht, The 
Netherlands 
1, M. Granzier1, W. Van Elmpt1, R. Biemans1, N. 
Lieuwes1, L. Dubois1, P. Lambin1 
 
Purpose or Objective: There are several potentially 
radioresistant targets for dose escalation in dose-painting 
apporoach. Among them tumor hypoxia is a very attractive 
target. However, 2-3 times higher radiation dose is required 
to overcome hypoxia-mediated radioresistance in tumors, 
which is clinically difficult to achieve due to normal tissues 
constraints. Therefore, we propose a novel treatment 
approach to combine 1) targeting hypoxic tumor cells with a 
hypoxia-activated prodrug (HAP) TH302 and 2) at the same 
time use inverse radiation dose-painting strategy to boost 
tumor subvolumes with no/low drug uptake. We tested this 
approach in a rat rhabdomyosarcoma model using 18F-HX4 
hypoxia tracer, which is a surrogate of TH302 accumulation in 
a tumor. 
 
Material and Methods: A clinical PET/CT scanner was used to 
evaluate 18F-HX4 uptake 3 hrs post injection. Low or high 
drug uptake volume (LDUV or HDUV) was defined as 40% of 
the GTV with the highest or the lowest 18F-HX4 uptake, i.e. 
TH302 accumulation. Within 24 hrs after PET/CT animals 
(n=9) received either a single dose radiotherapy (RT) 
uniformly or a dose-painted non-uniform irradiation with 50% 
higher dose to LDUV or to HDUV. Mean dose in uniform RT 
was 18.5 Gy similarly to the mean dose in DUV. Mean dose to 
the GTV in the non-uniform RT scenario was 14.9 Gy. 
Treatment plans were created using Eclipse treatment 
planning system. Animals were irradiated on a TrueBeam 
High Definition 120 Leaf MLC linac. Tumor response was 
quantified as time required to reach 3-times starting tumor 
volume (TGTV3). 
 
Results: Non-uniform RT with radiation boost to tumor 
subvolumes with low TH302 uptake (LDUV) was much more 
effective than the same dose escalation to subvolumes with 
high drug uptake (Fig. 1). Noteworthy, dose escalation to 
LDUV was as effective as uniform RT with 3.6 Gy higher mean 
dose to GTV. 
 
Fig. 1.Time to reach 3-times starting tumor volume (TGTV3) 
after uniform RT or non-uniform RT with dose escalation to 
tumor volume with high drug uptake (HDUV) or low drug 
uptake (LDUV). Mean dose (Dm) to GTV is indicated. 
 
Conclusion: The results of this pilot study support targeted 
dose escalation in non-hypoxic tumor subvolumes with 
no/low accumulation of hypoxia-activated prodrugs, which 
requires further confirmation. This strategy appears to be as 
effective as a uniform dose escalation of the entire GTV but 
with greater capacity to spare normal tissues. It is expected 
that this approach of inverse dose-painting can be combined 
with other imageable cytotoxic drugs, which warrants further 
investigations. 
 





How to bring QUANTEC into the 21st century? 
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The implicit concept behind the title of this lecture concerns 
the role of “quantitative” data-driven approaches in 
assessing dose-volume effects in normal tissues in the era of 
“high-tech” radiotherapy and integration of “omics”. The 
continuously growing literature regarding dose-volume 
relationships indirectly reflects the need of improving and 
refining our knowledge in this field [1]. This seems to be 
particularly urgent in a number of clinically relevant 
situations such as, for instance, heart, bowel and bladder. 
However, the impact of the above mentioned elements 
(“high-tech & “omics”) on the research issues of this field is 
increasingly relevant and claims for the development of new 
research lines and methods that will shortly be overviewed in 
the lecture.  
